Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies - PubMed (original) (raw)
. 1998 Nov;157(11):881-4.
doi: 10.1007/s004310050959.
Affiliations
- PMID: 9835429
- DOI: 10.1007/s004310050959
Prevalence of the microdeletion 22q11 in newborn infants with congenital conotruncal cardiac anomalies
L Iserin et al. Eur J Pediatr. 1998 Nov.
Abstract
Conotruncal malformations account for about 50% of congenital heart defects diagnosed in newborns. We studied prospectively 104 patients admitted in our neonatal intensive care unit for conotruncal defects by fluorescence in situ hybridization to estimate the prevalence of the interstitial deletion in this category of congenital heart disease. Cardiac phenotypes were: truncus arteriosus (17), interrupted aortic arch (18), tetralogy of Fallot with or without pulmonary valve atresia (55), tetralogy of Fallot with absent pulmonary valves (5), ventricular septal defect with malalignment of the conal septum (9). We discovered a microdeletion 22q11 at loci D22S39 or D22S398 in 50 newborns (48%). The prevalence of this microdeletion in different groups of conotruncal defects was: truncus arteriosus 7/17, interrupted aortic arch 16/18, tetralogy of Fallot 19/55, absent pulmonary valves 2/5, and ventricular septal defect 6/9 respectively. Only two patients without any clinical or biological feature of the so called CATCH22 syndrome exhibited the deletion. Parental studies confirmed that the deletion occurred de novo in 47/50 cases (three parental microdeletions). On the other hand, recurrence of conotruncal heart defects in families of "undeleted probands" was higher than expected (13%).
Conclusion: In 50/104 newborns with conotruncal defects, an interstitial deletion 22q11 was found. Fluorescence in Situ Hybridization should be performed in newborn infants with conotruncal defect and at least one additional manifestation of the CATCH22 phenotype.
Similar articles
- Chromosome 22q11.2 microdeletion in children with conotruncal heart defects: frequency, associated cardiovascular anomalies, and outcome following cardiac surgery.
Ziolkowska L, Kawalec W, Turska-Kmiec A, Krajewska-Walasek M, Brzezinska-Rajszys G, Daszkowska J, Maruszewski B, Burczynski P. Ziolkowska L, et al. Eur J Pediatr. 2008 Oct;167(10):1135-40. doi: 10.1007/s00431-007-0645-2. Epub 2008 Jan 3. Eur J Pediatr. 2008. PMID: 18172682 - [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2].
Trost D, Engels H, Bauriedel G, Wiebe W, Schwanitz G. Trost D, et al. Dtsch Med Wochenschr. 1999 Jan 8;124(1-2):3-7. doi: 10.1055/s-2008-1062601. Dtsch Med Wochenschr. 1999. PMID: 9951451 German. - Anatomic patterns of conotruncal defects associated with deletion 22q11.
Marino B, Digilio MC, Toscano A, Anaclerio S, Giannotti A, Feltri C, de Ioris MA, Angioni A, Dallapiccola B. Marino B, et al. Genet Med. 2001 Jan-Feb;3(1):45-8. doi: 10.1097/00125817-200101000-00010. Genet Med. 2001. PMID: 11339377 - Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome.
Carotti A, Digilio MC, Piacentini G, Saffirio C, Di Donato RM, Marino B. Carotti A, et al. Dev Disabil Res Rev. 2008;14(1):35-42. doi: 10.1002/ddrr.6. Dev Disabil Res Rev. 2008. PMID: 18636635 Review. - 22q11.2 deletion syndrome and congenital heart disease.
Goldmuntz E. Goldmuntz E. Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):64-72. doi: 10.1002/ajmg.c.31774. Epub 2020 Feb 12. Am J Med Genet C Semin Med Genet. 2020. PMID: 32049433 Review.
Cited by
- Clinical Features to Predict 22q11.2 Deletion Syndrome Proven by Molecular Genetic Testing.
Rojnueangit K, Khetkham T, Onsod P, Chareonsirisuthigul T. Rojnueangit K, et al. J Pediatr Genet. 2020 Oct 1;11(1):22-27. doi: 10.1055/s-0040-1718386. eCollection 2022 Mar. J Pediatr Genet. 2020. PMID: 35186386 Free PMC article. - Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.
Monteiro FP, Vieira TP, Sgardioli IC, Molck MC, Damiano AP, Souza J, Monlleó IL, Fontes MI, Fett-Conte AC, Félix TM, Leal GF, Ribeiro EM, Banzato CE, Dantas Cde R, Lopes-Cendes I, Gil-da-Silva-Lopes VL. Monteiro FP, et al. Eur J Pediatr. 2013 Jul;172(7):927-45. doi: 10.1007/s00431-013-1964-0. Epub 2013 Feb 26. Eur J Pediatr. 2013. PMID: 23440478 - Transcription factor pathways and congenital heart disease.
McCulley DJ, Black BL. McCulley DJ, et al. Curr Top Dev Biol. 2012;100:253-77. doi: 10.1016/B978-0-12-387786-4.00008-7. Curr Top Dev Biol. 2012. PMID: 22449847 Free PMC article. Review. - Frequency of 22q11.2 microdeletion in children with congenital heart defects in western poland.
Wozniak A, Wolnik-Brzozowska D, Wisniewska M, Glazar R, Materna-Kiryluk A, Moszura T, Badura-Stronka M, Skolozdrzy J, Krawczynski MR, Zeyland J, Bobkowski W, Slomski R, Latos-Bielenska A, Siwinska A. Wozniak A, et al. BMC Pediatr. 2010 Dec 6;10:88. doi: 10.1186/1471-2431-10-88. BMC Pediatr. 2010. PMID: 21134246 Free PMC article. - Investigating 22q11.2 deletion and other chromosomal aberrations in fetuses with heart defects detected by prenatal echocardiography.
Bellucco FT, Belangero SI, Farah LM, Machado MV, Cruz AP, Lopes LM, Lopes MA, Zugaib M, Cernach MC, Melaragno MI. Bellucco FT, et al. Pediatr Cardiol. 2010 Nov;31(8):1146-50. doi: 10.1007/s00246-010-9763-0. Epub 2010 Sep 17. Pediatr Cardiol. 2010. PMID: 20848279
MeSH terms
LinkOut - more resources
Full Text Sources
Medical